Rapidose Overview

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

Rapidose General Information

Description

Provider of paediatric drug dosing devices intended to ensure accurate, weight-based adrenaline dosing for children in cardiac arrest. The company's device allows clinicians to prepare accurate doses quickly in time-critical situations, using an intuitive, fast and reliable design created with frontline healthcare professionals, enabling clinicians working in ambulance services, rural healthcare settings and hospital emergency departments and supporting safer paediatric care by reducing dosing errors, improving confidence in drug preparation under pressure and helping expand access to appropriate, weight-based treatment for children.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Hadley, MA
  • United States
Primary Industry
Medical Supplies
Vertical(s)
HealthTech
Corporate Office
  • Hadley, MA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rapidose Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 01-Aug-2026 Completed Startup
5. Later Stage VC Completed Startup
4. Accelerator/Incubator 01-Jan-2025 Completed Startup
3. Early Stage VC 01-Jan-2022 Completed Startup
2. Accelerator/Incubator 01-Jan-2015 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Rapidose’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Rapidose Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rapidose Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
VentureLab (University of Auckland) Accelerator/Incubator
Cure Kids Ventures Venture Capital Minority
Flying Kiwi Angels Angel Group Minority
WNT Ventures Venture Capital Minority
To view Rapidose’s complete investors history, request access »

Ready to get started?

Request a free trial

Rapidose FAQs

  • Where is Rapidose headquartered?

    Rapidose is headquartered in Hadley, MA.

  • What is the size of Rapidose?

    Rapidose has 3 total employees.

  • What industry is Rapidose in?

    Rapidose’s primary industry is Medical Supplies.

  • Is Rapidose a private or public company?

    Rapidose is a Private company.

  • What is Rapidose’s current revenue?

    The current revenue for Rapidose is .

  • Who are Rapidose’s investors?

    VentureLab (University of Auckland), Cure Kids Ventures, Flying Kiwi Angels, and WNT Ventures have invested in Rapidose.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process